ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-5.07%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$262M
AUM Growth
+$262M
(-21%)
Cap. Flow
-$50.9M
Cap. Flow
% of AUM
-19.42%
Top 10 Holdings %
Top 10 Hldgs %
60.55%
Holding
81
New
18
Increased
11
Reduced
15
Closed
31
Top Buys
| 1 |
Qiagen
QGEN
|
$16.2M |
| 2 |
Boston Scientific
BSX
|
$15.6M |
| 3 |
Icon
ICLR
|
$10.8M |
| 4 |
Zoetis
ZTS
|
$7.07M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$5.82M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$15.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
$14.2M |
| 3 |
Orthofix Medical
OFIX
|
$14.2M |
| 4 |
Centene
CNC
|
$12.7M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$9.98M |
Sector Composition
| 1 | Healthcare | 76.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
AdaptHealth
AHCO
$1.23B
| – | – |
-248,314
| Closed | -$3.98M |
|
52
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
-10,379
| Closed | -$1.7M |
|
53
argenx
ARGX
$44.2B
| – | – |
-4,480
| Closed | -$1.41M |
|
|
54
AstraZeneca
AZN
$255B
| – | – |
-240,271
| Closed | -$15.9M |
|
|
55
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-194,684
| Closed | -$14.2M |
|
56
CareDx
CDNA
$678M
| – | – |
-28,048
| Closed | -$1.04M |
|
57
Charles River Laboratories
CRL
$7.99B
| – | – |
-3,308
| Closed | -$939K |
|
58
DarioHealth
DRIO
$22.6M
| – | – |
-3,689
| Closed | -$431K |
|
59
DaVita
DVA
$9.72B
| – | – |
0
| – | – |
|
60
Encompass Health
EHC
$12.5B
| – | – |
-82,526
| Closed | -$4.67M |
|
61
Edwards Lifesciences
EW
$47.7B
| – | – |
-44,561
| Closed | -$5.25M |
|
62
Gossamer Bio
GOSS
$587M
| – | – |
-68,710
| Closed | -$596K |
|
63
ICU Medical
ICUI
$3.06B
| – | – |
-6,093
| Closed | -$1.36M |
|
64
Idexx Laboratories
IDXX
$50.7B
| – | – |
-5,729
| Closed | -$3.13M |
|
65
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-60,720
| Closed | -$1.01M |
|
66
Intuitive Surgical
ISRG
$158B
| – | – |
-17,232
| Closed | -$5.2M |
|
67
Kezar Life Sciences
KZR
$28.5M
| – | – |
-5,947
| Closed | -$988K |
|
68
Mettler-Toledo International
MTD
$26.1B
| – | – |
-1,765
| Closed | -$2.42M |
|
69
Natera
NTRA
$23B
| – | – |
-24,747
| Closed | -$1.01M |
|
|
70
Orthofix Medical
OFIX
$583M
| – | – |
-434,803
| Closed | -$14.2M |
|
71
Premier
PINC
$2.11B
| – | – |
-75,632
| Closed | -$2.69M |
|
72
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|
73
Rhythm Pharmaceuticals
RYTM
$6.75B
| – | – |
-105,792
| Closed | -$1.22M |
|
74
Tandem Diabetes Care
TNDM
$834M
| – | – |
-18,236
| Closed | -$2.12M |
|
75
10x Genomics
TXG
$1.66B
| – | – |
-24,923
| Closed | -$1.9M |
|